Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics
Mudassir Hassan, Ijaz Hussain, Kafeel Ahmad, Saima Zafar, Adeel Khalid, Muhammad Haseeb, Nazim Hussain, Muhammad Adeel Ghafar · 2025
Read Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics by Mudassir Hassan, Ijaz Hussain, Kafeel Ahmad, Saima Zafar, Adeel Khalid, Muhammad Haseeb, Nazim Hussain, Muhammad Adeel Ghafar (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12744588.txt.
Description
Mudassir Hassan and co-authors review, in 2025, newer treatments for the most common form of primary liver cancer. The disease is usually found late, which limits options and worsens outlook. It grows out of chronic viral hepatitis, alcohol damage, and fatty liver disease, and its growth runs through a few well-known signaling routes.
Drawing on more than eighty recent studies, the review covers targeted drugs, immune checkpoint drugs, drug combinations, surgery, and local treatments. Tumor immunity, new markers, and tailoring therapy to each patient's tumor get special attention. The authors argue these strands together offer real chances to extend life and improve its quality.
Catalog record
| CREATOR | Mudassir Hassan, Ijaz Hussain, Kafeel Ahmad, Saima Zafar, Adeel Khalid, Muhammad Haseeb, Nazim Hussain, Muhammad Adeel Ghafar |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |